Dendritic cells acquire antigens from live cells for cross-presentation to CTL - PubMed (original) (raw)
Dendritic cells acquire antigens from live cells for cross-presentation to CTL
L A Harshyne et al. J Immunol. 2001.
Erratum in
- J Immunol 2001 May 1;166(9):5840
Abstract
Dendritic cells (DC) can readily capture Ag from dead and dying cells for presentation to MHC class I-restricted CTL. We now show by using a primate model that DC also acquire Ag from healthy cells, including other DC. Coculture assays showed that fluorescently labeled plasma membrane was rapidly and efficiently transferred between DC, and transfer of intracellular proteins was observed to a lesser extent. Acquisition of labeled plasma membrane and intracellular protein was cell contact-dependent and was primarily a function of immature DC, whereas both immature and CD40L-matured DC could serve as donors. Moreover, immature DC could acquire labeled plasma membrane and intracellular proteins from a wide range of hemopoietic cells, including macrophages, B cells, and activated T cells. Notably, macrophages, which readily phagocytose apoptotic bodies, were very inefficient at acquiring labeled plasma membrane and intracellular proteins from other live macrophages or DC. With live-cell imaging techniques, we demonstrate that individual DC physically extract plasma membrane from other DC, generating endocytic vesicles of up to 1 microm in diameter. Finally, DC but not macrophages acquired an endogenous melanoma Ag expressed by live DC and cross-presented Ag to MHC class I-restricted CTL, demonstrating the immunological relevance of our finding. These data show for the first time that DC readily acquire Ag from other live cells. We suggest that Ag acquisition from live cells may provide a novel mechanism whereby DC can present Ag in the absence of direct infection, and may serve to expand and regulate the immune response in vivo.
Similar articles
- A role for class A scavenger receptor in dendritic cell nibbling from live cells.
Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM. Harshyne LA, et al. J Immunol. 2003 Mar 1;170(5):2302-9. doi: 10.4049/jimmunol.170.5.2302. J Immunol. 2003. PMID: 12594251 - Generation of tumor-reactive CTL against the tumor-associated antigen HER2 using retrovirally transduced dendritic cells derived from CD34+ hemopoietic progenitor cells.
Meyer zum Büschenfelde C, Nicklisch N, Rose-John S, Peschel C, Bernhard H. Meyer zum Büschenfelde C, et al. J Immunol. 2000 Oct 1;165(7):4133-40. doi: 10.4049/jimmunol.165.7.4133. J Immunol. 2000. PMID: 11034426 - Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses.
Fonteneau JF, Larsson M, Bhardwaj N. Fonteneau JF, et al. Curr Opin Immunol. 2002 Aug;14(4):471-7. doi: 10.1016/s0952-7915(02)00358-8. Curr Opin Immunol. 2002. PMID: 12088682 Review. - Interaction of regulatory T cells with antigen-presenting cells in health and disease.
Mahnke K, Ring S, Bedke T, Karakhanova S, Enk A. Mahnke K, et al. Chem Immunol Allergy. 2008;94:29-39. doi: 10.1159/000154854. Chem Immunol Allergy. 2008. PMID: 18802334 Review.
Cited by
- Molecular Characteristics, Functional Definitions, and Regulatory Mechanisms for Cross-Presentation Mediated by the Major Histocompatibility Complex: A Comprehensive Review.
Liu S, Wei S, Sun Y, Xu G, Zhang S, Li J. Liu S, et al. Int J Mol Sci. 2023 Dec 22;25(1):196. doi: 10.3390/ijms25010196. Int J Mol Sci. 2023. PMID: 38203367 Free PMC article. Review. - Cell-targeted vaccines: implications for adaptive immunity.
Ung T, Rutledge NS, Weiss AM, Esser-Kahn AP, Deak P. Ung T, et al. Front Immunol. 2023 Aug 16;14:1221008. doi: 10.3389/fimmu.2023.1221008. eCollection 2023. Front Immunol. 2023. PMID: 37662903 Free PMC article. Review. - Pathways of MHC I cross-presentation of exogenous antigens.
Cruz FM, Chan A, Rock KL. Cruz FM, et al. Semin Immunol. 2023 Mar;66:101729. doi: 10.1016/j.smim.2023.101729. Epub 2023 Feb 16. Semin Immunol. 2023. PMID: 36804685 Free PMC article. Review. - Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy.
Makandar AI, Jain M, Yuba E, Sethi G, Gupta RK. Makandar AI, et al. Vaccines (Basel). 2022 Nov 30;10(12):2049. doi: 10.3390/vaccines10122049. Vaccines (Basel). 2022. PMID: 36560459 Free PMC article. Review. - Intracellular monitoring by dendritic cells - a new way to stay informed - from a simple scavenger to an active gatherer.
Herbst C, Harshyne LA, Igyártó BZ. Herbst C, et al. Front Immunol. 2022 Oct 27;13:1053582. doi: 10.3389/fimmu.2022.1053582. eCollection 2022. Front Immunol. 2022. PMID: 36389660 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials